Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHemogenyx Regulatory News (HEMO)

Share Price Information for Hemogenyx (HEMO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.50
Bid: 1.48
Ask: 1.546
Change: 0.00 (0.00%)
Spread: 0.066 (4.459%)
Open: 1.50
High: 0.00
Low: 0.00
Prev. Close: 1.50
HEMO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

25 Nov 2015 11:56

RNS Number : 9401G
Silver Falcon PLC
25 November 2015
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

SILVER FALCON PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Abdelatif LACHAB

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

25/11/2015

6. Date on which issuer notified:

25/11/2015

7. Threshold(s) that is/are crossed orreached: vi, vii

4%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

2,300,000

2,300,000

2,600,000

2,600,000

4%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

2,600,000

4%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Abdelatif Lachab

15. Contact telephone number:

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLPGGAAGUPAGGA
Date   Source Headline
13th Nov 20179:00 amRNSPrice Monitoring Extension
13th Nov 20177:00 amRNSStatement re Press Comment
30th Oct 20177:00 amRNSLakePharma appointed for lead product development
11th Oct 20177:00 amRNSDirector/PDMR Shareholding
10th Oct 20177:00 amRNSDirector/PDMR Shareholding
5th Oct 20178:01 amRNSCornell University update
5th Oct 20178:00 amRNSAdmission & First Day of Dealings
4th Oct 201711:16 amRNSResult of General Meeting
26th Sep 20177:00 amRNSInvestor presentations
25th Sep 20177:00 amRNSHalf-year Report
11th Sep 20177:00 amRNSProposed acquisition and Placing & Subscription
13th Apr 20173:30 pmRNSFinal Results
30th Sep 20162:00 pmRNSProposed acquisition of Lime Holdings Limited
5th Aug 20167:00 amRNSInterim Report for the period ended 30 June 2016
29th Jun 20167:00 amRNSResults of Annual General Meeting
1st Jun 20169:43 amRNSPosting of Annual Report & Accounts
28th Apr 20167:00 amRNSFinal Results for period ended 31 December 2015
18th Feb 201610:33 amRNSChange of Accounting Reference Date
30th Dec 20157:00 amRNSStatement re possible acquisition
23rd Dec 201512:48 pmRNSSuspension of trading
23rd Dec 201512:45 pmRNSSuspension
18th Dec 201511:07 amRNSAppointment of Financial Advisor
7th Dec 20155:36 pmRNSStatement re: media speculation
27th Nov 20153:00 pmRNSInterim Report for the period ended 31 August 2015
25th Nov 201511:56 amRNSHolding(s) in Company
17th Nov 20153:26 pmRNSHolding(s) in Company
16th Nov 201512:47 pmRNSHolding(s) in Company
16th Nov 20157:00 amRNSAppointment of Broker
11th Nov 20155:15 pmRNSHolding(s) in Company
9th Nov 20157:00 amRNSPlacing of Shares & admission to Official List LSE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.